Variant report
Variant | esv2591572 |
---|---|
Chromosome Location | chr6:29762698-29764237 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:61)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29763945-29763995 | A549 | lung: | n/a |
2 | chr6:29763945-29763995 | AG10803 | skin: | n/a |
3 | chr6:29763945-29763995 | AG04450 | lung: | fetal |
4 | chr6:29763945-29763995 | GM19239 | blood: | n/a |
5 | chr6:29763945-29763995 | HRPEpiC | eye: | n/a |
6 | chr6:29763945-29763995 | HRCEpiC | kidney: | n/a |
7 | chr6:29763945-29763995 | AoSMC | blood vessel: | n/a |
8 | chr6:29763945-29763995 | HCT-116 | colon: | n/a |
9 | chr6:29763945-29763995 | BE2_C | brain: | n/a |
10 | chr6:29763945-29763995 | HUVEC | blood vessel: | n/a |
11 | chr6:29763945-29763995 | HEK293 | kidney: | embryo |
12 | chr6:29763945-29763995 | CMK | blood: | n/a |
13 | chr6:29763945-29763995 | SK-N-SH_RA | brain: | n/a |
14 | chr6:29763945-29763995 | SK-N-MC | brain: | n/a |
15 | chr6:29763945-29763995 | HepG2 | liver: | n/a |
16 | chr6:29763945-29763995 | AG09309 | skin: | n/a |
17 | chr6:29763945-29763995 | NB4 | blood: | n/a |
18 | chr6:29763945-29763995 | AG09319 | gingival: | n/a |
19 | chr6:29763945-29763995 | H1-hESC | embryonic stem cell: | embryo |
20 | chr6:29763945-29763995 | MCF10A-Er-Src | breast: | n/a |
21 | chr6:29763945-29763995 | HCM | heart: | n/a |
22 | chr6:29763945-29763995 | T-47D | breast: | n/a |
23 | chr6:29763945-29763995 | NHDF-neo | bronchial: | n/a |
24 | chr6:29763945-29763995 | NHBE | bronchial: | n/a |
25 | chr6:29763945-29763995 | IMR90 | lung: | fetal |
26 | chr6:29763945-29763995 | ECC-1 | luminal epithelium: | n/a |
27 | chr6:29763945-29763995 | HAEpiC | amniotic membrane: | n/a |
28 | chr6:29763945-29763995 | Hepatocyte | liver: | n/a |
29 | chr6:29763945-29763995 | GM12892 | blood: | n/a |
30 | chr6:29763945-29763995 | HL-60 | blood: | n/a |
31 | chr6:29763945-29763995 | RPTEC | kidney: | n/a |
32 | chr6:29763945-29763995 | ovcar-3 | ovarian: | n/a |
33 | chr6:29763945-29763995 | AG04449 | skin: | fetal |
34 | chr6:29763945-29763995 | K562 | blood: | n/a |
35 | chr6:29763945-29763995 | NH-A | brain: | n/a |
36 | chr6:29763945-29763995 | HCPEpiC | choroid plexus: | n/a |
37 | chr6:29763945-29763995 | PANC-1 | pancreas: | n/a |
38 | chr6:29763945-29763995 | HPAEpiC | pulmonary alveolar: | n/a |
39 | chr6:29763945-29763995 | PFSK-1 | brain: | n/a |
40 | chr6:29763945-29763995 | Jurkat | blood: | n/a |
41 | chr6:29763945-29763995 | Caco-2 | colon: | n/a |
42 | chr6:29763945-29763995 | GM12891 | blood: | n/a |
43 | chr6:29763945-29763995 | HCF | heart: | n/a |
44 | chr6:29763945-29763995 | U87 | brain: | n/a |
45 | chr6:29763945-29763995 | HIPEpiC | eye: | n/a |
46 | chr6:29763945-29763995 | HRE | kidney: | n/a |
47 | chr6:29763945-29763995 | GM12878 | blood: | n/a |
48 | chr6:29763945-29763995 | MCF-7 | breast: | n/a |
49 | chr6:29763945-29763995 | HNPCEpiC | eye: | n/a |
50 | chr6:29763945-29763995 | SK-N-SH | brain: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29760049..29761986-chr6:29763646..29765387,2 | K562 | blood: | |
2 | chr6:29764068..29767781-chr6:29769569..29773130,4 | K562 | blood: | |
3 | chr6:29760873..29763751-chr6:29786445..29789008,2 | MCF-7 | breast: | |
4 | chr6:29763208..29764709-chr6:29776682..29778485,2 | MCF-7 | breast: | |
5 | chr6:29762168..29764765-chr6:29782319..29784097,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HCG4 | TF binding region |
HLA-P | TF binding region |
HCG4 | CpG island |
HLA-P | CpG island |
ENSG00000213880 | chromatin interactions |
ENSG00000176998 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs386698461 | chr6:29762729-29762730 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs58477674 | chr6:29762730-29762731 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs370226633 | chr6:29762764-29762765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73403721 | chr6:29762814-29762815 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs199596044 | chr6:29762826-29762827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557861605 | chr6:29762838-29762839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs59396305 | chr6:29762839-29762840 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs377240930 | chr6:29762868-29762869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77894866 | chr6:29762875-29762876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1737002 | chr6:29762903-29762904 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs59408697 | chr6:29762928-29762929 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs1633010 | chr6:29762942-29762943 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs540632366 | chr6:29762946-29762947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56182102 | chr6:29762955-29762956 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs56183732 | chr6:29762970-29762971 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs543576751 | chr6:29762972-29762973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140378769 | chr6:29762995-29762996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116313505 | chr6:29762998-29762999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs56241766 | chr6:29762999-29763000 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs542420664 | chr6:29763026-29763027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562210390 | chr6:29763058-29763059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59508891 | chr6:29763066-29763067 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs56315562 | chr6:29763072-29763073 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs564177988 | chr6:29763077-29763078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114462371 | chr6:29763078-29763079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1633009 | chr6:29763087-29763088 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs72507838 | chr6:29763094-29763095 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs201761668 | chr6:29763111-29763112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200209097 | chr6:29763112-29763113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200711018 | chr6:29763113-29763114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565806174 | chr6:29763114-29763115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542526407 | chr6:29763115-29763116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565030251 | chr6:29763116-29763117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372565958 | chr6:29763126-29763127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10546744 | chr6:29763128-29763129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373874335 | chr6:29763158-29763159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116408465 | chr6:29763175-29763176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142099983 | chr6:29763212-29763213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184575048 | chr6:29763213-29763214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189810811 | chr6:29763238-29763239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148859015 | chr6:29763297-29763298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201408142 | chr6:29763299-29763300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368116837 | chr6:29763302-29763303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78960639 | chr6:29763303-29763304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9258407 | chr6:29763307-29763308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13437595 | chr6:29763308-29763309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9258408 | chr6:29763311-29763312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201683757 | chr6:29763315-29763316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs58553945 | chr6:29763316-29763317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
50 | rs572637121 | chr6:29763318-29763319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29760400-29764400 | Weak transcription | Hela-S3 | cervix |
2 | chr6:29761000-29763000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr6:29761000-29765200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr6:29761200-29763800 | Weak transcription | HMEC | breast |
5 | chr6:29761200-29763800 | Weak transcription | NHEK | skin |
6 | chr6:29761200-29764400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr6:29761400-29763800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr6:29761800-29766200 | Weak transcription | Pancreas | Pancrea |
9 | chr6:29762200-29764600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr6:29762600-29762800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr6:29763000-29763800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr6:29763800-29764800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr6:29763800-29766000 | Enhancers | HMEC | breast |
14 | chr6:29763800-29766200 | Enhancers | NHEK | skin |
15 | chr6:29763800-29766800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr6:29764000-29766000 | Enhancers | NHDF-Ad | bronchial |